The Aminobisphosphonate Risedronate Preserves Localized Mineral and Material Properties of Bone in the Presence of Glucocorticoids

OBJECTIVE. Glucocorticoids (GCs) alter bone strength such that patients receiving these medications have a high rate of fragility-related fractures. The purpose of this study was to assess whether concurrent treatment with GCs (prednisolone) and risedronate (an aminobisphosphonate) would prevent the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheum
Main Authors: Balooch, Guive, Yao, Wei, Ager, Joel W., Balooch, Mehdi, Nalla, Ravi K., Porter, Alexandra E., Ritchie, Robert O., Lane, Nancy E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913894/
https://ncbi.nlm.nih.gov/pubmed/17968931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.22976
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados